Microfluidics Market Size & Share | Industry Growth by 2027

report image

Microfluidics Market to 2027 – COVID-19 Impact and Global Analysis – by Product (Microfluidic Chips, Microfluidic Sensors, Devices, Micropumps, Microneedles, and Other Products), Material (PDMS, Polymers, Glass, Silicon, and Other Materials), and Application (In Vitro Diagnostics, Pharmaceutical and Life Science Research, Drug Discovery, and Other Applications)

Publication Month: Jul 2020 | Report Code: TIPHE100000953 | No. of Pages: 182 | Category: Biotechnology | Status: Published

The microfluidics market size is estimated to reach US$ 43,398.7 million by 2027 from US$ 11,851.1 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2019 to 2027.

Microfluidics involves various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. It is an emerging technology having a wide range of applications in biology, chemistry, optics, and information technology. This technology is widely used in techniques such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, and PCR amplification. Additionally, microfluidics is used in disease research and diagnosis. The microfluidics market growth is attributed owing to innovations in microfluidics products, high-throughput screening methodologies, in vitro diagnostics (IVD), and development of advanced lab-on-a-chip technologies. However, the lower adoption of these products in emerging economies may hinder the growth of the market.

Lucrative Regions for Microfluidics Market

Get more information on this report :

Market Insights

Innovation in Microfluidics Products

The increasing technological advancements in diagnostic devices and the rising incidence of chronic diseases are encouraging the adoption of microfluidics in disease diagnosis. The market is witnessing the launch of numerous technologically advanced products, such as 3D lab-on-a-chip devices. These advancements are leading to the evolution of a cost-effective mass-production of diagnostic devices in a wide range of diagnostic applications. Microfluidics have a potential role in creating accurate wearable technology. A recent study by the researchers showed that microchannels and micro reservoirs, pre-filled with fluorescent probes react to target analytes in sweat and can perform quantitative analysis. To capture sweat, fluorometric sensing modalities were integrated into a skin-interfaced microfluidic system paired with a smartphone-based imaging module. This method resulted in an accurate measurement of biomarkers in sweat. Researchers developed wearable sensors to monitor biomolecule levels by combining continuous fluid sampling with in-situ analysis. Depending upon the target biomolecule, the particular assay is interchangeable. The microfluidic device featured a droplet-flow method for timing and a micropump to produce nanolitre-sized droplets. Biomarker variations within fluids, over time, yield insight into tissue physiology and may help create personalized treatments for patients, thus resulting in better healthcare outcomes. Also, key market players have been introducing new products to strengthen their market position.

A few major product launches are mentioned below:

•     In February 2020, Miroculus, Inc. unveiled its Miro Canvas at the Advances in Genome Biology and Technology conference. The Miro Canvas system automates and miniaturizes complex protocols such as NGS library prep and improving library consistency. Also, it decreases sample input requirements and reagent volumes.

•     In January 2020, Nicoya launched the Alto surface plasmon resonance (SPR) system. It is a first fully-automated, high-throughput system that integrates digital microfluidics (DMF), artificial intelligence (AI), and nanotechnology. It offers high-quality, label-free interaction analysis. This product was designed to reduce the time and cost of drug discovery.

•     In November 2019, MicroMedicine, Inc. launched Sorterra Cell Isolation System. This new, patented automated technology isolates white blood cells from human peripheral blood using microfluidic channels without centrifugation or labeling.

Product-Based Insights

The global microfluidics market, based on product, is segmented into microfluidic chips, microfluidic sensors, devices, micropumps, microneedles, and other products. The devices segment held the largest share in 2019 and is expected to witness the highest growth from 2019 to 2027. The devices offer a vast variety of applications in many research areas and numerous benefits such as increased precision, shortened experiment time, and cost savings. Microfluidic devices exploit the physical and chemical properties of liquids and gases at a microscale. Microfluidic devices offer several advantages and benefits over conventionally sized systems. Microfluidics allows the analysis and use of less volume of samples, chemicals and reagents reducing the global fees of applications.

Material-Based Insights

The global microfluidics market, based on material, is segmented into PDMS, polymers, glass, silicon, and others. The PDMS segment held the largest share in 2019 and is expected to witness the fastest growth rate from 2019 to 2027. PDMS deformability permits easy connections of leak-proof fluidic connections, integration of fluidic valves through PDMS microchannels and is used to detect low forces such as biomechanics interactions from cells. The molding step allows mass-production of microfluidic chips from a mold. 

Application-Based Insights

The global microfluidics market, based on application, is segmented into in-vitro diagnostics, pharmaceutical and life science research, drug discovery, and other applications. The in-vitro diagnostics segment held the largest share in 2019 and is expected to witness the highest growth from 2019 to 2027. In vitro diagnostic (IVD) is an important component of clinical care, which contributes to the prevention, diagnosis, treatment, and management of diverse diseases by the analysis of biomolecules from body fluids, including proteins, nucleic acids, and small molecule metabolites

Strategic Insights

Report Coverage - Microfluidics Market
Report CoverageDetails
Market Size Value inUS$ 11,851.1 million in 2019
Market Size Value byUS$ 43,398.7 million by 2027
Growth rateCAGR of 17.9% from 2019 to 2027.
Forecast Period2019-2027
Base Year2019
No. of Pages182
No. of Tables94
No. of Charts & Figures76
Historical data availableYes
Segments coveredProduct, Material, and Application
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the microfluidics market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The microfluidics market share is anticipated to flourish with the development of new innovative products by market players. Some of the companies that have been included in our research scope are Agilent Technologies, Inc.; BD; Bio-Rad Laboratories Inc.; Danaher; Dolomite Microfluidics (Blacktrace Holdings Ltd.); Fludigm Corporation; Illumina, Inc.; microfluidic ChipShop GmbH; Perkin Elmer, Inc.; Thermo Fisher Scientific Inc.; CMC Microsystems; Epigem; FlowJEM; Quidel Corporation; and Abaxis, Inc.  

Frequently Asked Questions

Microfluidics involves processing or manipulation of small amount of fluidics. It studies various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. Microfluidics is an emerging technology having a wide range of applications in biology, chemistry, optics and information technology. This technology is widely used for various processes such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, PCR amplification, among others. Additionally, microfluidics is also used in the diagnosis of diseases such as cancer and research.
Factors such as rising demand for microfluidics technologies in point-of-care testing and innovation in microfluidics product portfolio are expected to boost the growth of the global microfluidics market. However, the market is likely to get impacted by the lower adoption in emerging economies during the forecast period.
Global microfluidics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North American region held the largest market share in the global scenario. Factors such as technological advancements, new product launches and increasing R&D activities are likely to be responsible for the domination of North America in the microfluidics market. In addition, growing research technologies, and novel methods for manufacturing liposomes are also expected to boost the growth of the market in North America.

The List of Companies - Microfluidics Market

  1. Agilent Technologies, Inc.
  2. BD
  3. Bio-Rad Laboratories Inc.,
  4. Danaher
  5. Dolomite Microfluidics (Blacktrace Holdings Ltd.)
  6. Fludigm Corporation
  7. Illumina, Inc.
  8. microfluidic ChipShop GmbH
  9. Perkin Elmer, Inc.
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the microfluidics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global microfluidics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount